Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Molly Went¹, Amit Sud¹, Asta Försti^{2

3}, Britt-Marie Halvarsson⁴, Niels Weinhold^{5

6}, Scott Kimber⁷, Mark van Duin⁸, Gudmar Thorleifsson⁹, Amy Holroyd¹, David C Johnson⁷, Ni Li¹, Giulia Orlando¹, Philip J Law¹, Mina Ali⁴, Bowang Chen², Jonathan S Mitchell¹, Daniel F Gudbjartsson^{9

10}, Rowan Kuiper⁸, Owen W Stephens⁵, Uta Bertsch^{2

11}, Peter Broderick¹, Chiara Campo², Obul R Bandapalli², Hermann Einsele¹², Walter A Gregory¹³, Urban Gullberg⁴, Jens Hillengass⁶, Per Hoffmann^{14

15}, Graham H Jackson¹⁶, Karl-Heinz Jöckel¹⁷, Ellinor Johnsson⁴, Sigurður Y Kristinsson¹⁸, Ulf-Henrik Mellqvist¹⁹, Hareth Nahi²⁰, Douglas Easton^{21

22}, Paul Pharoah^{21

22}, Alison Dunning²¹, Julian Peto²³, Federico Canzian²⁴, Anthony Swerdlow^{1

25}, Rosalind A Eeles^{1

26}, Zsofia Kote-Jarai¹, Kenneth Muir^{27

28}, Nora Pashayan^{21

29}; PRACTICAL consortium; Jolanta Nickel⁶, Markus M Nöthen^{14

30}, Thorunn Rafnar⁹, Fiona M Ross³¹, Miguel Inacio da Silva Filho², Hauke Thomsen², Ingemar Turesson³², Annette Vangsted³³, Niels Frost Andersen³⁴, Anders Waage³⁵, Brian A Walker⁵, Anna-Karin Wihlborg⁴, Annemiek Broyl⁸, Faith E Davies⁵, Unnur Thorsteinsdottir^{9

36}, Christian Langer³⁷, Markus Hansson^{4

32}, Hartmut Goldschmidt^{6

11}, Martin Kaiser⁷, Pieter Sonneveld⁸, Kari Stefansson⁹, Gareth J Morgan⁵, Kari Hemminki^{38

39}, Björn Nilsson^{40

41}, Richard S Houlston^{42

43}

Collaborators, Affiliations

Collaborators

PRACTICAL consortium:
Brian E Henderson, Christopher A Haiman, Sara Benlloch, Fredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, David V Conti, Fredrik Wiklund, Stephen Chanock, Victoria L Stevens, Catherine M Tangen, Jyotsna Batra, Judith Clements, Henrik Gronberg, Johanna Schleutker, Demetrius Albanes, Stephanie Weinstein, Alicja Wolk, Catharine West, Lorelei Mucci, Géraldine Cancel-Tassin, Stella Koutros, Karina Dalsgaard Sorensen, Eli Marie Grindedal, David E Neal, Freddie C Hamdy, Jenny L Donovan, Ruth C Travis, Robert J Hamilton, Sue Ann Ingles, Barry Rosenstein, Yong-Jie Lu, Graham G Giles, Adam S Kibel, Ana Vega, Manolis Kogevinas, Kathryn L Penney, Jong Y Park, Janet L Stanford, Cezary Cybulski, Børge G Nordestgaard, Hermann Brenner, Christiane Maier, Jeri Kim, Esther M John, Manuel R Teixeira, Susan L Neuhausen, Kim De Ruyck, Azad Razack, Lisa F Newcomb, Davor Lessel, Radka Kaneva, Nawaid Usmani, Frank Claessens, Paul A Townsend, Manuela Gago-Dominguez, Monique J Roobol, Florence Menegaux, Kay-Tee Khaw, Lisa Cannon-Albright, Hardev Pandha, Stephen N Thibodeau

Affiliations

¹ Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
² German Cancer Research Center, 69120, Heidelberg, Germany.
³ Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden.
⁴ Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.
⁵ Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
⁶ Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
⁷ Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.
⁸ Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
⁹ deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
¹⁰ School of Engineering and Natural Sciences, University of Iceland, IS-101, Reykjavik, Iceland.
¹¹ National Centre of Tumor Diseases, 69120, Heidelberg, Germany.
¹² University Clinic of Würzburg, 97080, Würzburg, Germany.
¹³ Clinical Trials Research Unit, University of Leeds, Leeds, LS2 9PH, UK.
¹⁴ Institute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.
¹⁵ Division of Medical Genetics, Department of Biomedicine, University of Basel, 4003, Basel, Switzerland.
¹⁶ Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
¹⁷ Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, D-45147, Germany.
¹⁸ Department of Hematology, Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland.
¹⁹ Section of Hematology, Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden.
²⁰ Center for Hematology and Regenerative Medicine, SE-171 77, Stockholm, Sweden.
²¹ Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
²² Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
²³ Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
²⁴ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
²⁵ Division of Breast Cancer Research, The Institute of Cancer Research, London, SW7 3RP, UK.
²⁶ Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK.
²⁷ Institute of Population Health, University of Manchester, Manchester, M13 9PL, UK.
²⁸ Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
²⁹ Department of Applied Health Research, University College London, London, WC1E 7HB, UK.
³⁰ Department of Genomics, Life & Brain Center, University of Bonn, D-53127, Bonn, Germany.
³¹ Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, SP2 8BJ, UK.
³² Hematology Clinic, Skåne University Hospital, SE-221 85, Lund, Sweden.
³³ Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
³⁴ Department of Haematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000, Aarhus C, Denmark.
³⁵ Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491, Trondheim, Norway.
³⁶ Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland.
³⁷ Department of Internal Medicine III, University of Ulm, D-89081, Ulm, Germany.
³⁸ German Cancer Research Center, 69120, Heidelberg, Germany. K.Hemminki@dkfz-heidelberg.de.
³⁹ Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden. K.Hemminki@dkfz-heidelberg.de.
⁴⁰ Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.
⁴¹ Broad Institute, 7 Cambridge Center, Cambridge, MA, 02142, USA. bjorn.nilsson@med.lu.se.
⁴² Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.
⁴³ Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.

PMID: 30631080
PMCID: PMC6328616
DOI: 10.1038/s41467-018-08107-8

Published Erratum

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Molly Went et al. Nat Commun. 2019.

. 2019 Jan 10;10(1):213.

doi: 10.1038/s41467-018-08107-8.

Authors

Collaborators

PRACTICAL consortium:
Brian E Henderson, Christopher A Haiman, Sara Benlloch, Fredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, David V Conti, Fredrik Wiklund, Stephen Chanock, Victoria L Stevens, Catherine M Tangen, Jyotsna Batra, Judith Clements, Henrik Gronberg, Johanna Schleutker, Demetrius Albanes, Stephanie Weinstein, Alicja Wolk, Catharine West, Lorelei Mucci, Géraldine Cancel-Tassin, Stella Koutros, Karina Dalsgaard Sorensen, Eli Marie Grindedal, David E Neal, Freddie C Hamdy, Jenny L Donovan, Ruth C Travis, Robert J Hamilton, Sue Ann Ingles, Barry Rosenstein, Yong-Jie Lu, Graham G Giles, Adam S Kibel, Ana Vega, Manolis Kogevinas, Kathryn L Penney, Jong Y Park, Janet L Stanford, Cezary Cybulski, Børge G Nordestgaard, Hermann Brenner, Christiane Maier, Jeri Kim, Esther M John, Manuel R Teixeira, Susan L Neuhausen, Kim De Ruyck, Azad Razack, Lisa F Newcomb, Davor Lessel, Radka Kaneva, Nawaid Usmani, Frank Claessens, Paul A Townsend, Manuela Gago-Dominguez, Monique J Roobol, Florence Menegaux, Kay-Tee Khaw, Lisa Cannon-Albright, Hardev Pandha, Stephen N Thibodeau

Affiliations

¹ Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
² German Cancer Research Center, 69120, Heidelberg, Germany.
³ Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden.
⁴ Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.
⁵ Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
⁶ Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
⁷ Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.
⁸ Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
⁹ deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
¹⁰ School of Engineering and Natural Sciences, University of Iceland, IS-101, Reykjavik, Iceland.
¹¹ National Centre of Tumor Diseases, 69120, Heidelberg, Germany.
¹² University Clinic of Würzburg, 97080, Würzburg, Germany.
¹³ Clinical Trials Research Unit, University of Leeds, Leeds, LS2 9PH, UK.
¹⁴ Institute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.
¹⁵ Division of Medical Genetics, Department of Biomedicine, University of Basel, 4003, Basel, Switzerland.
¹⁶ Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
¹⁷ Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, D-45147, Germany.
¹⁸ Department of Hematology, Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland.
¹⁹ Section of Hematology, Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden.
²⁰ Center for Hematology and Regenerative Medicine, SE-171 77, Stockholm, Sweden.
²¹ Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
²² Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
²³ Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
²⁴ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
²⁵ Division of Breast Cancer Research, The Institute of Cancer Research, London, SW7 3RP, UK.
²⁶ Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK.
²⁷ Institute of Population Health, University of Manchester, Manchester, M13 9PL, UK.
²⁸ Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
²⁹ Department of Applied Health Research, University College London, London, WC1E 7HB, UK.
³⁰ Department of Genomics, Life & Brain Center, University of Bonn, D-53127, Bonn, Germany.
³¹ Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, SP2 8BJ, UK.
³² Hematology Clinic, Skåne University Hospital, SE-221 85, Lund, Sweden.
³³ Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
³⁴ Department of Haematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000, Aarhus C, Denmark.
³⁵ Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491, Trondheim, Norway.
³⁶ Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland.
³⁷ Department of Internal Medicine III, University of Ulm, D-89081, Ulm, Germany.
³⁸ German Cancer Research Center, 69120, Heidelberg, Germany. K.Hemminki@dkfz-heidelberg.de.
³⁹ Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden. K.Hemminki@dkfz-heidelberg.de.
⁴⁰ Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.
⁴¹ Broad Institute, 7 Cambridge Center, Cambridge, MA, 02142, USA. bjorn.nilsson@med.lu.se.
⁴² Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.
⁴³ Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.

PMID: 30631080
PMCID: PMC6328616
DOI: 10.1038/s41467-018-08107-8

Abstract

The original version of this Article contained an error in the spelling of a member of the PRACTICAL Consortium, Manuela Gago-Dominguez, which was incorrectly given as Manuela Gago Dominguez. This has now been corrected in both the PDF and HTML versions of the Article. Furthermore, in the original HTML version of this Article, the order of authors within the author list was incorrect. The PRACTICAL consortium was incorrectly listed after Richard S. Houlston and should have been listed after Nora Pashayan. This error has been corrected in the HTML version of the Article; the PDF version was correct at the time of publication.

PubMed Disclaimer

Erratum for

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.
Went M, Sud A, Försti A, Halvarsson BM, Weinhold N, Kimber S, van Duin M, Thorleifsson G, Holroyd A, Johnson DC, Li N, Orlando G, Law PJ, Ali M, Chen B, Mitchell JS, Gudbjartsson DF, Kuiper R, Stephens OW, Bertsch U, Broderick P, Campo C, Bandapalli OR, Einsele H, Gregory WA, Gullberg U, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Johnsson E, Kristinsson SY, Mellqvist UH, Nahi H, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N, Nickel J, Nöthen MM, Rafnar T, Ross FM, da Silva Filho MI, Thomsen H, Turesson I, Vangsted A, Andersen NF, Waage A, Walker BA, Wihlborg AK, Broyl A, Davies FE, Thorsteinsdottir U, Langer C, Hansson M, Goldschmidt H, Kaiser M, Sonneveld P, Stefansson K, Morgan GJ, Hemminki K, Nilsson B, Houlston RS; PRACTICAL consortium. Went M, et al. Nat Commun. 2018 Sep 13;9(1):3707. doi: 10.1038/s41467-018-04989-w. Nat Commun. 2018. PMID: 30213928 Free PMC article.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Collaborators

Affiliations

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Authors

Collaborators

Affiliations

Abstract

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources